Novo invests $6B in Wegovy production, still below demand

By Reuters
| November 13, 2023

Obesity drug maker Novo Nordisk will spend $6 billion to boost production in Denmark, although its CEO warned the industry was far from being able to meet global demand.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...